A three-pronged approach was followed for deducing the pharmaceutical contract manufacturing and research services market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:
Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for pharmaceutical contract manufacturing and research services market to gather the most reliable and current information possible.
Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of pharmaceutical contract manufacturing and research services market data depending on the type of information we’re trying to uncover in our research.
Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.
Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.
Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.
Qualitative Functional Deployment (QFD) Modelling for market share assessment.
Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.
Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.
Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.
This step also entails the finalization of the report scope and data representation pattern.
Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.
The pharmaceutical contract manufacturing and research services market was categorized into two segments, namely service (Manufacturing, Research), and regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).
The pharmaceutical contract manufacturing and research services market was segmented into service, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:
Demand estimation of each product across countries/regions summed up to from the total market.
Variable analysis for demand forecast.
Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.
Primary interviews for data revalidation and insight collection.
Used extensively for new product forecasting or analyzing penetration levels.
Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.
Primary interviews and vendor-based primary research for variable impact analysis.
The pharmaceutical contract manufacturing and research services market was analyzed at a regional level. The global was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-six countries, namely, the U.S., Canada, the UK, Germany, France, Italy, Spain, Norway, Sweden, Denmark, China, Japan, India, South Korea, Thailand, Australia, Brazil, Argentina, Colombia, Chile, Venezuela, Mexico, South Africa, Saudi Arabia, UAE, Kuwait.
All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.
The pharmaceutical contract manufacturing and research services market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:
Boehringer Ingelheim: Boehringer Ingelheim is committed to research & development of therapeutics for humans and animals. It operates in different countries, including the U.S., the UK, Europe, and Asia. The company operates in various therapeutic areas such as respiratory, central nervous, cardiovascular, & metabolic systems and virological diseases & oncology. Boehringer BioXcellence is a subsidiary of the parent group that operates in the contract manufacturing space and caters to pharmaceutical & biotechnology companies. The company offers a portfolio of technologies, including the production of antibodies, nonantibody scaffolds, recombinant proteins, Fab fragments, and pDNA from either microbial fermentation or mammalian cell culture systems.
Lonza: Lonza is a Switzerland-based CDMO that provides development and manufacturing services for biologics, small molecules, & gene therapy, among others. The company provides wide range of products and services ranging from early phase discovery to custom development & manufacturing of APIs (active pharmaceutical ingredient). Lonza has worldwide operations in North America, Europe, and Asia with strong presence in France, the UK, and other countries.
Grifols SA: Grifols SA is a healthcare provider engaged in marketing & distribution of biotechnological and pharmaceutical products. It primarily operates in four major divisions: bioscience, diagnostics, bio supplies, and hospitals. The company provides medical products & services to medical and healthcare professionals in over 90 countries. It is majorly involved in the development and commercialization of protein & plasma-derived products for the treatment of diseases like autoimmune disorders and primary immunodeficiency diseases. Moreover, it specializes in transfusion medicine, clinical analysis, development of intensive care products, and medical devices for use in hospital pharmacy, automated compounding, clinical nutrition, and fluid therapy.
Jubilant Life Sciences: In February 2021, the name of Jubilant Life Sciences Limited business was changed to Jubilant Pharmova Limited. Jubilant Pharmova Limited is a global pharmaceutical and life sciences company focused on the development & manufacturing of APIs, allergy therapy products, solid dosage formulations, radiopharmaceuticals, fine ingredients, advance intermediates, life sciences chemicals, and nutritional products. It also provides contract manufacturing services for drug discovery solutions and sterile injectable.
Pfizer (CentreOne): Pfizer is a U.S.-based pharmaceutical company, which operates in three business segments: Biopharma, Pfizer CentreOne, and Consumer Health. The company operates as a CDMO through its subsidiary Pfizer CentreOne. The subsidiary participates in the development and manufacturing of small molecules, large molecules, oral solids, and sterile injectables. Pfizer CentreOne develops API and Intermediates. Pfizer CentreOne provides its services both drug substance and drug products.
Charles River Laboratories International, Inc.: Charles River Laboratories International, Inc. offers solutions and services in research, clinical support, drug discovery, safety & efficacy assessment, and process manufacturing services to biotechnology, governments, pharmaceutical, & academic organizations around the world. Its therapeutic areas include cardiovascular, inflammation, musculoskeletal, respiratory, and CNS metabolic diseases as well as oncology and ophthalmology. The company’s product portfolio includes biomarkers, cellular therapeutics, biosimilars, and vaccines. This company was formerly known as CRL Holdings, Inc. and in September 1999, it changed its name to Charles River Laboratories, Inc. The company operates in Australia, Canada, China, Finland, and the U.S. It operates as a subsidiary of Charles River Laboratories International, Inc.
Albany Molecular Research, Inc.: In July 2021, Albany Molecular Research, Inc. changed its name to Curia. Curia is a global contract research & manufacturing organization involved in drug discovery, development, and cGMP manufacturing. The company is headquartered in Albany, New York, & the U.S. and was established in 1991. The company has its facilities located in the U.S., Germany, the UK, India, and Spain.
Laboratory Corporation of America Holdings (LabCorp): LabCorp operates in the healthcare services industry, offering clinical diagnostics, drug development, contract research organization services, drug monitoring solutions, and technology solutions. They provide comprehensive laboratory testing, pathology services, molecular diagnostics, and genomic testing for medical conditions. LabCorp also supports pharmaceutical and biotech companies with clinical trials, central laboratory testing, and safety assessment. Additionally, they offer drug monitoring services for medication management and workplace drug testing programs. LabCorp invests in technology solutions to enhance laboratory processes and patient outcomes.
IQVIA: IQVIA Holdings, Inc., formerly known as Quintiles and IMS Health, Inc., is a provider of technology solutions, advanced analytics, and clinical research services. The company’s offerings are majorly provided to life sciences industries. The company operates in three major segments namely Research & Development Solutions, Technology & Analytics Solutions, and Contract Sales & Medical Solutions. The company offers its services in various therapeutic areas such as oncology, rare diseases, infectious diseases, diabetes, and others.
Baxter BioPharma Solutions: BioPharma Solutions is a business unit of Baxter International. The company collaborates with pharmaceutical companies to help pharmaceutical companies achieve their marketing objectives by providing expertise and procedures in sterile contract manufacturing, parenteral delivery, and some of the customized support services, which are required for the development of parenteral products. The company has over 50 manufacturing facilities across six continents with its presence in the U.S., Brazil, Spain, France, China, Singapore, and Poland, among other countries.
Supply Side Estimates
Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.
Segment revenue determination via variable analysis and penetration modeling.
Competitive benchmarking to identify market leaders and their collective revenue shares.
Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.
Demand side estimates
Identifying parent markets and ancillary markets
Segment penetration analysis to obtain pertinent
Heuristic forecasting with the help of subject matter experts
Forecasting via variable analysis
Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.
Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.
Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.
The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.
The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.
We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.
All market estimates and forecasts have been validated through primary interviews with the key industry participants.
Inflation has not been accounted for to estimate and forecast the market.
Numbers may not add up due to rounding off.
Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).
Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).
Latin America includes Central American countries and the South American continent
Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.
GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.
We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:
Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.
Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.
The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.
GET A FREE SAMPLE
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member